Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3200
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04074460 | Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study | ||
| NCT05034562 | Gallium-68 PSMA-11 PET in Participants With Prostate Cancer | ||
| NCT00038883 | Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies | ||
| NCT00645541 | Axillary Reverse Mapping for Invasive Carcinoma of the Breast | ||
| NCT03111069 | Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children | ||
| NCT01003054 | Autologous Transplantation for Chronic Myelogenous Leukemia | ||
| NCT05501054 | Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma. | ||
| NCT02363491 | A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome | ||
| NCT00761618 | Intrapleural Catheter Daily Versus Three Times a Week Drainage | ||
| NCT07153796 | A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia | ||
| NCT05273554 | A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma | ||
| NCT05322135 | A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma | ||
| NCT00495040 | Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT02420691 | Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin | ||
| NCT07137390 | A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer | ||
| NCT06817720 | Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase | ||
| NCT06545682 | Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) | ||
| NCT03763162 | Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT05017103 | Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study | ||
| NCT00501826 | Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | ||
| NCT01619774 | An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor | ||
| NCT02481297 | Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients | ||
| NCT04872413 | Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial | ||
| NCT03868020 | Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease | ||
| NCT00522223 | Sexual Functioning in Cervical Cancer Survivors | ||
| NCT00673179 | Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy | ||
| NCT02960646 | Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies | ||
| NCT06036810 | Spanish Decision Tool for Ovarian Cancer Maintenance Therapy | ||
| NCT07032727 | Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations | ||
| NCT05634525 | Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients | ||
| NCT07137468 | Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk | ||
| NCT00512096 | Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | ||
| NCT00662662 | Sexual Behavior in Head and Neck Cancer Patients | ||
| NCT00535873 | Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older | ||
| NCT04516070 | Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis | ||
| NCT03193970 | Measuring Surgical Recovery After Radical Cystectomy | ||
| NCT01740570 | Phase I/II Cabazitaxel for Recurrent Malignant Glioma | ||
| NCT00454766 | Evaluating Materials to Educate Patients About Cervical Dysplasia | ||
| NCT00500565 | Pain Management Following TRAM Flap for Breast Reconstruction | ||
| NCT00493467 | Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas | ||
| NCT01746836 | Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib | ||
| NCT00038207 | Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies | ||
| NCT01134575 | CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) | ||
| NCT01319981 | Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia | ||
| NCT00778375 | Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) | ||
| NCT03056339 | Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies | ||
| NCT02420912 | Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation | ||
| NCT06409065 | Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers | ||
| NCT04985565 | Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer | ||
| NCT06535828 | AIM4 AI and Mechanistic Modeling in Molecular Medicine |
